Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
OrthoPediatrics
KIDS
OrthoPediatrics
Rising Global Costs Will Constrain Revenue While Clinics Persist
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
08 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$22.00
12.8% undervalued
intrinsic discount
16 Aug
US$19.19
Loading
1Y
-32.9%
7D
2.0%
Author's Valuation
US$22.0
12.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$22.0
12.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-42m
344m
2014
2017
2020
2023
2025
2026
2028
Revenue US$344.5m
Earnings US$42.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
16.06%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.97%
Calculation
US$42.79m
Earnings '28
x
17.47x
PE Ratio '28
=
US$747.71m
Market Cap '28
US$747.71m
Market Cap '28
/
27.84m
No. shares '28
=
US$26.86
Share Price '28
US$26.86
Share Price '28
Discounted to 2025 @ 7.97% p.a.
=
US$21.34
Fair Value '25
